Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 15, 2019 - Issue 1
Submit an article Journal homepage
1,266
Views
17
CrossRef citations to date
0
Altmetric
Research Paper

Comparative effectiveness of H7N9 vaccines in healthy individuals

Dan ZhengDepartment of Research and Development, Shanghai Institute of Biological Products, Shanghai, China;Shanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Vascular Disease, Shanghai TCM-Integrated Institute of Vascular Disease, Shanghai, ChinaView further author information
,
Feixia GaoDepartment of Research and Development, Shanghai Institute of Biological Products, Shanghai, ChinaView further author information
,
Cheng ZhaoShanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Vascular Disease, Shanghai TCM-Integrated Institute of Vascular Disease, Shanghai, ChinaView further author information
,
Yahong DingDepartment of Research and Development, Shanghai Institute of Biological Products, Shanghai, ChinaView further author information
,
Yemin CaoShanghai TCM-Integrated Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China;Department of Vascular Disease, Shanghai TCM-Integrated Institute of Vascular Disease, Shanghai, ChinaView further author information
,
Tianhan YangDepartment of Research and Development, Shanghai Institute of Biological Products, Shanghai, ChinaView further author information
,
Xuesong XuHuadong Hospital Affiliated to Fudan University, Shanghai, ChinaView further author information
&
Ze ChenDepartment of Research and Development, Shanghai Institute of Biological Products, Shanghai, ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 80-90 | Received 17 Apr 2018, Accepted 19 Aug 2018, Published online: 14 Sep 2018

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhaoxue Hu, Yifei Yang, Lincheng Fang, Jinpei Zhou & Huibin Zhang. (2021) Insight into the dichotomous regulation of STING activation in immunotherapy. Immunopharmacology and Immunotoxicology 43:2, pages 126-137.
Read now

Articles from other publishers (16)

Shintaro Shichinohe & Tokiko Watanabe. (2023) Advances in Adjuvanted Influenza Vaccines. Vaccines 11:8, pages 1391.
Crossref
Siqi Liu, Guozhong Yang, Minghui Li, Fang Sun, Yufeng Li, Xiliang Wang, Yunhua Gao & Penghui Yang. (2022) Transcutaneous immunization via dissolving microneedles protects mice from lethal influenza H7N9 virus challenge. Vaccine 40:47, pages 6767-6775.
Crossref
Tazio Vanni, Beatriz C. Thomé, Erin Sparrow, Martin Friede, Christopher B. Fox, Anna Marie Beckmann, Chuong Huynh, Gabriella Mondini, Daniela H. Silveira, Juliana Y. K. Viscondi, Patrícia Emilia Braga, Anderson da Silva, Maria da Graça Salomão, Roberta O. Piorelli, Joane P. Santos, Vera Lúcia Gattás, Maria Beatriz B. Lucchesi, Mayra M. M. de Oliveira, Marcelo E. Koike, Esper G. Kallas, Lucia M. A. Campos, Eduardo B. Coelho, Marilda A. M. Siqueira, Cristiana C. Garcia, Milene Dias Miranda, Terezinha M. Paiva, Maria do Carmo S. T. Timenetsky, Eduardo A. Adami, Milena A. Akamatsu, Paulo Lee Ho & Alexander R. Precioso. (2022) Dose-sparing effect of two adjuvant formulations with a pandemic influenza A/H7N9 vaccine: A randomized, double-blind, placebo-controlled, phase 1 clinical trial. PLOS ONE 17:10, pages e0274943.
Crossref
Yulia Desheva, Igor Losev, Nadezhda Petkova, Polina Kudar, Svetlana Donina, Andrey Mamontov, Chih-Hsuan Tsai & Yu-Chan Chao. (2022) Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years. Pharmaceuticals 15:9, pages 1127.
Crossref
Min-Yuan Chia, Chun-Yang Lin, Po-Ling Chen, Chia-Chun Lai, Tsai-Chuan Weng, Wang-Chou Sung, Alan Yung-Chih Hu & Min-Shi Lee. (2022) Characterization and Immunogenicity of Influenza H7N9 Vaccine Antigens Produced Using a Serum-Free Suspension MDCK Cell-Based Platform. Viruses 14:9, pages 1937.
Crossref
Adinda Kok, Ron A. M. Fouchier & Mathilde Richard. (2021) Cross-Reactivity Conferred by Homologous and Heterologous Prime-Boost A/H5 Influenza Vaccination Strategies in Humans: A Literature Review. Vaccines 9:12, pages 1465.
Crossref
Shilei Wang, Zhiqiang Xie, Lili Huang, Xu Zhou, Jian Luo, Yuelian Yang, Changgui Li, Peng Duan, Wenting Xu, Dandan Chen, Bing Wu, Yongli Yang, Xueying Liu, Yanxia Wang, Zhenghong Yuan, Di Qu, Ze Chen & Shengli Xia. (2021) Safety and immunogenicity of an alum-adjuvanted whole-virion H7N9 influenza vaccine: a randomized, blinded, clinical trial. Clinical Microbiology and Infection 27:5, pages 775-781.
Crossref
Eduardo Alfredo Adami, Stefanni Liliane Chavez Rico, Milena Apetito Akamatsu, Cosue Miyaki, Isaías Raw, Dourival de Oliveira, Priscila Comone, Ricardo das Neves Oliveira, Maria Leonor Sarno de Oliveira, Patrícia Antônia Estima Abreu, Carolina Yumi Takano, Maurício Meros, Alessandra Soares-Schanoski & Paulo Lee Ho. (2021) H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine. Biochemical and Biophysical Research Communications 545, pages 145-149.
Crossref
Erin Sparrow, James G Wood, Christopher Chadwick, Anthony T. Newall, Siranda Torvaldsen, Ann Moen & Guido Torelli. (2021) Global production capacity of seasonal and pandemic influenza vaccines in 2019. Vaccine 39:3, pages 512-520.
Crossref
Jin Il Kim, Sehee Park, Joon-Yong Bae, Sunmi Lee, Jeonghun Kim, Gayeong Kim, Kirim Yoo, Jun Heo, Yong Seok Kim, Jae Soo Shin, Mee Sook Park & Man-Seong Park. (2020) Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus. PLOS Biology 18:12, pages e3001024.
Crossref
Jingdi Pan & Zongqiang Cui. (2020) Self‐Assembled Nanoparticles: Exciting Platforms for Vaccination. Biotechnology Journal 15:12.
Crossref
Deepak S. Chauhan, Rajendra Prasad, Rohit Srivastava, Meena Jaggi, Subhash C. Chauhan & Murali M. Yallapu. (2020) Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2. Bioconjugate Chemistry 31:9, pages 2021-2045.
Crossref
Irina Kiseleva, Irina Isakova-Sivak, Marina Stukova, Marianna Erofeeva, Svetlana Donina, Natalie Larionova, Elena Krutikova, Ekaterina Bazhenova, Ekaterina Stepanova, Kirill Vasilyev, Victoria Matyushenko, Marina Krylova, Julia Galatonova, Aleksey Ershov, Dmitry Lioznov, Erin Grace Sparrow, Guido Torelli & Larisa Rudenko. (2020) A Phase 1 Randomized Placebo-Controlled Study to Assess the Safety, Immunogenicity and Genetic Stability of a New Potential Pandemic H7N9 Live Attenuated Influenza Vaccine in Healthy Adults. Vaccines 8:2, pages 296.
Crossref
Milena Apetito Akamatsu, Vitor Anselmo Sakihara, Bianca Pereira Carvalho, Aline de Paiva Abrantes, Maria A. Sakauchi Takano, Eduardo Alfredo Adami, Fernando Seiji Yonehara, Patrícia dos Santos Carneiro, Stefanni Rico, Alessandra Schanoski, Maurício Meros, Adrian Simpson, Tony Phan, Christopher B. Fox & Paulo Lee Ho. (2020) Preparedness against pandemic influenza: Production of an oil-in-water emulsion adjuvant in Brazil. PLOS ONE 15:6, pages e0233632.
Crossref
Peter Pushko & Irina Tretyakova. (2020) Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development. Viruses 12:5, pages 518.
Crossref
Jian Luo, Xu-ping Liu, Fei-fei Xiong, Fei-xia Gao, Ying-lei Yi, Min Zhang, Ze Chen & Wen-song Tan. (2019) Enhancing Immune Response and Heterosubtypic Protection Ability of Inactivated H7N9 Vaccine by Using STING Agonist as a Mucosal Adjuvant. Frontiers in Immunology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.